Trials / Sponsors / Apollomics Inc.
Apollomics Inc.
Industry · 5 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | A Study Comparing Two Different Capsules, APL-101 and PLB-1001 Capsules, in Healthy Chinese and Caucasian Part Bioequivalence | Phase 1 | 2022-05-20 |
| Terminated | Study to Evaluate the Efficacy of Uproleselan in Combination With Chemotherapy in Chinese Patients With R/R AM Relapsed/Refractory AML | Phase 3 | 2021-11-17 |
| Suspended | APL-102 Capsule in Patients With Advanced Solid Tumors Advanced Solid Tumor | Phase 1 | 2021-08-02 |
| Completed | Study to Evaluate PK and Safety With Uproleselan Combined With Chemotherapy to Treat Chinese R/R AML Patients Relapsed/Refractory AML | Phase 1 | 2021-02-24 |
| Recruiting | APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Solid Tumors, Advanced Cancer, Renal Cancer | Phase 2 | 2017-09-27 |